EuroPCR: DISRUPT CAD III’s Impact on Clinical Practice
In case you missed its live airing, tune into a great discussion from coronary IVL’s most knowledgeable operators about how they are treating severely calcified lesions, their tips and tricks using IVL in real world practice as well as their clinical experience with IVL.
They answer your top questions as well as discuss the impact of the new Disrupt CAD III results on your clinical practice. For your convenience, we’ve included the sponsored webinar discussion below featuring Prof. Michael Haude from Neuss, Germany, Dr. Benjamin Honton from Toulouse, France and Prof. Emanuele Barbato from Naples, Italy. Enjoy!
Important Safety Information - Coronary IVL
Caution: In the United States, Shockwave C2 Coronary IVL catheters are investigational devices, limited by United States law to investigational use. DISRUPT CAD III Study
Shockwave C2 Coronary IVL catheters are commercially available in certain countries outside the U.S. Please contact your local Shockwave representative for specific country availability. The Shockwave C2 Coronary IVL catheters are indicated for lithotripsy-enhanced, low-pressure balloon dilatation of calcified, stenotic de novo coronary arteries prior to stenting. For the full IFU containing important safety information please visit: https://shockwavemedical.com/clinicians/international/coronary/shockwave-c2/
